Sign in
← Back to SCR 1
SCR 1 · Version I

Introduced

90R3033 KRT-D

By: Menéndez S.C.R. No. 1

CONCURRENT RESOLUTION

WHEREAS, Lobular breast cancer, also known as invasive lobular carcinoma (ILC), accounts for 10 to 15 percent of all new breast cancer diagnoses in the U.S. each year; and
WHEREAS, The second most common type of breast cancer, ILC originates in the lobules, or milk-producing glands, of the breast; according to the American Cancer Society, incidence rates of this subtype are rising faster than other cancers, and approximately 48,000 new cases are diagnosed every year, with more than two-thirds occurring in women over the age of 60; and
WHEREAS, ILC has distinct biological characteristics that make diagnosis and treatment particularly challenging; the tumors grow in single-file strands rather than in a lump, and they are also more likely to occur in more than one location or in both breasts; this makes physical examinations, screening, and advanced imaging tools such as mammography and ultrasound less reliable methods for early detection, often leading to later, more advanced stages of the disease at the time of diagnosis; and
WHEREAS, Though chemotherapy is not generally effective against ILC, the majority of lobular tumors are hormone receptor-positive, making endocrine therapy a common treatment; however, genetic mutations can cause therapeutic resistance, and scientists are working to boost patient participation in clinical trials to help advance research surrounding treatments and management; and
WHEREAS, To help focus attention on the disease, Lobular Breast Cancer Awareness Day takes place each year on October 15; the observance is recognized in numerous U.S. states as well as in countries around the globe, and the initiative is helping highlight the seriousness and prevalence of ILC and the importance of further medical studies; and
WHEREAS, Lobular Breast Cancer Awareness Day plays an important role in fostering greater understanding of this potentially deadly disease, and this worthwhile initiative is helping to ensure that more people with ILC receive the timely care that they need; now, therefore, be it
RESOLVED, That the 90th Legislature of the State of Texas hereby designate October 15 as Lobular Breast Cancer Awareness Day; and, be it further
RESOLVED, That, in accordance with the provisions of Section 391.004(d), Government Code, this designation remain in effect until the 10th anniversary of the date this resolution is finally passed by the legislature.
SCR 1 Version I | 51capitol